The Reporting Persons do not believe that the Proposed Transaction is in the best interest of the Issuer’s stockholders and currently opposes the Proposed Transaction. The Reporting Persons intend to vote against the Proposed Transaction and any related proposals presented to the Issuer’s stockholders for approval at the Special Meeting. In addition, in connection with the Special Meeting, the Reporting Persons intend to file proxy materials with the SEC and; once definitive proxy materials have been filed with the SEC, solicit proxies from the Issuer’s shareholders (my comment: that's us!!) to vote “AGAINST” the Proposed Transaction. The Reporting Persons may take other action in order to prevent the consummation of the Proposed Transaction, including the commencement of legal proceedings.
It's not definite that Alpha will sue OncoSec but, this is an option that's on the table.
It is understandable why Alpha is p.o.'ed. Welcome to the club.
Since Alpha is the largest holder(as of now),I'm hoping they will have something to do about that $2.50 price tag of the new deal.That 2.50 needs shareholder approval too, it's not a done deal yet, right? So let's hope that the 2.50 and also the 4.50 is still on the negotiating table, either with other bidders or even with CGP.The conflict might help in raising both those #s.